Investor directory

Bloomage Biotechnology

Bloomage BioTechnology (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) and focuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963.
http://www.biohyalux.com
http://www.bloomagebio-tech.com
http://www.bloomagebioactive.com
http://www.bloomagefreda.com
https://crunchbase.com/organization/bloomage-biotechnology-corporation-limited
https://facebook.com/bloomagebiotech
https://linkedin.com/company/bloomage-biotechnology-corporation-limited
https://pitchbook.com/profiles/company/114793-21
https://twitter.com/bloomagebiotech
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=49039924

Jin Xuekun

CEO and Executive Director

1 past transactions

Shanhai Innovation

Series A in 2022
Shanhai Innovation is a biological development company focused on supramolecular science and technology research and development. It provides supramolecular material, organic liquid, ionic salt, and biocatalysis. It serves biomedicine, daily cosmetics, health food, medical equipment, and food additives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.